TAPSE/RVSP ratio as an echocardiographic marker of residual risk in HFrEF patients receiving vericiguat
11 December 2025 (08:30 - 09:15)
Organised by: 

Abstract
Slides
About the speaker

Korea University Anam Hospital, Seoul (Korea (Republic of))
4 More presentations in this session
Doctor E. Stavropoulou (Thessaloniki, GR)
Associate Professor B. Kim (Busan, KR)
Doctor M. Friedrich (Montreal, CA)
Access the full session
The Event
EACVI 2025
11 December 2025
08:30 CET


